An interventional study of Virtual Reality in Cutaneous Leishmaniasis, Pain and Anxiety, sponsored by Stanford University. Not yet recruiting. Open to participants aged 5 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by Stanford University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this clinical trial is to learn whether immersive technology (virtual reality) headsets can reduce procedural pain and anxiety during diagnosis, intralesional and intramuscular injections, and wound/dressing care in pediatric patients 5 years of age and older and adult patients with cutaneous leishmaniasis receiving treatment at the MSF clinic in Peshawar, Khyber Pakhtunkhwa, Pakistan.
104 studies on the registry are indexed under Leishmaniasis, Cutaneous; 19 are open to participants now.
This study's planned enrollment of 15 is below the median of 60 across 77 interventional studies indexed under Leishmaniasis, Cutaneous.
Browse Leishmaniasis, Cutaneous studies →Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Virtual Reality
Participants interact with virtual reality games designed for procedural distraction while receiving medical treatment. Following treatment completion, participants undergo brief surveys and a semi-structured interview.
Participant feasibility and acceptability regarding immersive technology
Qualitative evaluation of participant attitudes, perceptions, and user experience with immersive technology headsets collected via semi-structured focus group interviews. Feedback will be categorized into core thematic domains including ease of use, comfort, and willingness to use in future care.
Time frame: Immediately after intervention
No study locations are listed for this record.
Start is estimated for Jan 2027; primary completion for Dec 2027, 11 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.